High-yield overview
Patient Blood Management
HighestTransfusion rate in ortho (~15% spine)
TXAAntifibrinolytic - the key agent
ProneFree abdomen - reduce venous engorgement
PBMPre/intra/post multimodal bundle
Key features
Why spine bleeds
PatternSpine (especially DEFORMITY/scoliosis and revision) surgery causes high blood loss - large exposures, cancellous bone bleeding, long operative time, the epidural VENOUS PLEXUS - and has the HIGHEST transfusion rate of the major orthopaedic procedures (around 15%).
Treatment
The strategy
PatternPATIENT BLOOD MANAGEMENT (PBM): a MULTIMODAL bundle across PREOPERATIVE (optimise anaemia/iron, manage anticoagulants), INTRAOPERATIVE (TRANEXAMIC ACID, hypotensive anaesthesia, prone positioning, haemostasis, cell salvage, staging) and POSTOPERATIVE (restrictive transfusion) phases.
Treatment
TXA
PatternTRANEXAMIC ACID, an antifibrinolytic, is the cornerstone agent - it reduces intraoperative bleeding, cell-saver volume and operative time (higher weight-based dosing more effective in deformity surgery) without a clear increase in complications; ABSENCE of TXA is an independent predictor of transfusion.
Treatment
Critical Must-Knows
- Spine surgery - particularly DEFORMITY (scoliosis) correction, multilevel fusion and revision - causes substantial blood loss because of large exposures, bleeding from cancellous (decorticated/osteotomised) bone, long operative times, and the EPIDURAL VENOUS PLEXUS, and it has the HIGHEST blood-transfusion rate among the major orthopaedic procedures (reported around 15%, versus a few percent for hip/knee arthroplasty).
- The modern approach is PATIENT BLOOD MANAGEMENT (PBM) - a MULTIMODAL, multidisciplinary bundle applied across the preoperative, intraoperative and postoperative phases - because no single measure suffices and the goal is to minimise both blood loss and the need for (and risks of) allogeneic transfusion.
- PREOPERATIVELY, the key modifiable factor is ANAEMIA: a low preoperative haemoglobin is the strongest independent predictor of transfusion, so iron-deficiency/anaemia should be identified and treated (oral or intravenous iron, with erythropoiesis-stimulating agents in selected cases) before major elective spine surgery, and antiplatelet/anticoagulant agents managed appropriately.
- INTRAOPERATIVELY, TRANEXAMIC ACID (an antifibrinolytic) is the cornerstone pharmacological measure - it significantly reduces intraoperative bleeding, cell-saver volume and operative time (with higher weight-based dosing more effective in adolescent deformity surgery) and is not associated with a clear increase in complications; the ABSENCE of TXA is itself an independent predictor of transfusion.
- Other INTRAOPERATIVE measures are PRONE POSITIONING with a FREE ABDOMEN (using a Wilson frame/Jackson table/chest rolls to keep the abdomen hanging free), which lowers intra-abdominal/caval pressure and reduces epidural venous engorgement and bleeding; controlled HYPOTENSIVE anaesthesia; meticulous surgical HAEMOSTASIS (bipolar, bone wax, topical haemostatic agents); intra-operative CELL SALVAGE for high-volume cases; and STAGING very large reconstructions.
- POSTOPERATIVELY, a RESTRICTIVE transfusion strategy (transfusing for symptomatic anaemia or a lower haemoglobin threshold rather than liberally) is used, with continued iron and monitoring; the overall PBM bundle reduces transfusion exposure and its risks, and risk stratification (low preoperative haemoglobin, high-risk procedure, ASA III-IV, no TXA, older age) identifies patients who most need these measures.
Clinical Pearls
- “Spine (deformity/revision) surgery = HIGH blood loss + the HIGHEST transfusion rate in ortho (~15%); epidural venous plexus + cancellous bleeding.
- “TRANEXAMIC ACID is the cornerstone agent (reduces bleeding/cell-saver volume/op time; higher weight-based dose more effective in deformity); absence of TXA predicts transfusion.
- “Multimodal PBM: preop anaemia/iron optimisation; intraop TXA + free-abdomen prone positioning + hypotensive anaesthesia + cell salvage + staging; postop restrictive transfusion.
Plan for Bleeding - Spine Surgery Transfuses the Most
Why
Large exposures, cancellous bleeding, long cases and the epidural venous plexus - spine (deformity) surgery has the highest transfusion rate in orthopaedics (~15%).
The bundle
PBM: optimise anaemia/iron preop; TXA + free-abdomen prone positioning + cell salvage intraop; restrictive transfusion postop.
Why Spine Bleeds & the Multimodal Bundle
A Multimodal Patient-Blood-Management Strategy
Spine surgery - especially deformity correction, multilevel fusion and revision - bleeds heavily because of large exposures, bleeding cancellous bone, long operative times and the epidural venous plexus, and it has the highest transfusion rate of the major orthopaedic procedures (around 15%). The answer is patient blood management (PBM), a multimodal bundle: preoperatively optimise anaemia (treat iron-deficiency, a low preoperative haemoglobin is the strongest transfusion predictor) and manage anticoagulants; intraoperatively use tranexamic acid (the cornerstone antifibrinolytic), prone positioning with a free abdomen (to reduce epidural venous engorgement), controlled hypotensive anaesthesia, meticulous haemostasis, cell salvage for high-volume cases, and staging very large reconstructions; and postoperatively transfuse restrictively. No single measure suffices.
| Phase | Measures | Goal |
|---|---|---|
| Preoperative | Identify/treat anaemia (iron +/- ESA); manage antiplatelet/anticoagulant; autologous planning | Raise the starting haemoglobin; reduce transfusion need |
| Intraoperative (pharmacologic) | Tranexamic acid (antifibrinolytic; higher weight-based dose in deformity) | Reduce bleeding, cell-saver volume, operative time |
| Intraoperative (technical) | Free-abdomen prone positioning; hypotensive anaesthesia; meticulous haemostasis; cell salvage; staging | Reduce venous engorgement and surgical blood loss; recycle red cells |
| Postoperative | Restrictive transfusion thresholds; continue iron; monitor | Limit allogeneic transfusion and its risks |
Tranexamic Acid & Positioning
The Two Highest-Yield Intraoperative Levers
- Tranexamic acid (TXA): the cornerstone agent - an antifibrinolytic that reduces intraoperative bleeding, cell-saver volume and operative time; in adolescent deformity surgery, higher weight-based dosing is more effective, without a clear increase in complications. The absence of TXA is an independent predictor of transfusion.
- Free-abdomen prone positioning: position prone on a frame/table (Wilson frame, Jackson table, chest rolls) so the abdomen hangs free, lowering intra-abdominal and caval pressure and reducing epidural venous engorgement and bleeding - a simple, powerful technical measure.
- Supporting measures: controlled hypotensive anaesthesia (within safe limits for cord perfusion), meticulous haemostasis, intra-operative cell salvage for high-volume cases, and staging very large cases.
- Risk-stratify: low preoperative haemoglobin, a high-risk procedure, ASA III-IV, no TXA and older age all raise transfusion risk - target the bundle at those patients.
Optimise Anaemia First, Give TXA, Free the Abdomen
Three measures carry most of the benefit and should not be omitted. First, OPTIMISE PREOPERATIVE ANAEMIA: a low preoperative haemoglobin is the strongest independent predictor of transfusion, so elective major spine surgery should not proceed without identifying and treating iron-deficiency anaemia. Second, give TRANEXAMIC ACID: it is the cornerstone antifibrinolytic, reduces bleeding and cell-saver volume, and its absence independently predicts transfusion. Third, POSITION PRONE WITH A FREE ABDOMEN, because a compressed abdomen raises caval pressure and engorges the epidural venous plexus, increasing bleeding. Combine these with cell salvage, controlled hypotension (kept safe for spinal cord perfusion) and a restrictive postoperative transfusion threshold, and risk-stratify so the most vulnerable patients receive the fullest bundle.
Evidence & Key Studies
Evidence
Optimal tranexamic acid dosing for adolescent idiopathic scoliosis surgery (network meta-analysis)
Lajczak P, Ayesha A, Ahmed AR, Chochol P, von Quednow E, Rocha FVV, et al. • Spine (2025)
Key Findings:
- Tranexamic acid is an antifibrinolytic widely used in spine surgery; in AIS instrumentation, higher weight-based dosing (a 100 mg/kg bolus plus 10 mg/kg/hr infusion) was most effective at reducing intraoperative bleeding, operative time and cell-saver volume.
- Lower doses also helped but less so; there was no difference in complication rates between doses (though not uniformly reported).
- TXA dosing meaningfully affects blood loss in adolescent deformity surgery (network meta-analysis of 1,523 patients across 16 studies).
Evidence
Independent preoperative predictors of red-cell transfusion in major orthopaedic surgery
Ortiz-Gomez JR, Ortiz-Dominguez A, Fornet-Ruiz I, Palacio-Abizanda FJ • Brazilian Journal of Anesthesiology (2025)
Key Findings:
- Spine surgery had the highest transfusion rate among major orthopaedic procedures (15%, versus 3.6% hip and 2.7% knee) in a cohort of 7,072 patients.
- Independent predictors of transfusion included low preoperative haemoglobin (under 13 g/dL; relative risk 6.55), high-risk procedure (RR 7.40), ASA III-IV (RR 2.00), ABSENCE of tranexamic acid (RR 2.52) and older age.
- These findings support patient blood management strategies (anaemia optimisation and routine TXA) to reduce transfusion.
Evidence Attribution
According to PubMed, the role and dosing of tranexamic acid in adolescent deformity surgery (higher weight-based dosing most effective, without a clear increase in complications) come from the cited Lajczak network meta-analysis; the highest-in-orthopaedics spine transfusion rate (about 15%) and the independent transfusion predictors (low preoperative haemoglobin, high-risk procedure, ASA III-IV, absence of TXA, older age) from the cited Ortiz-Gomez cohort. The broader patient-blood-management bundle - preoperative anaemia/iron optimisation, free-abdomen prone positioning to reduce epidural venous engorgement, hypotensive anaesthesia, cell salvage, staging and restrictive postoperative transfusion - is standard, well-established teaching. (See also our Adolescent Idiopathic Scoliosis and Adult Spinal Deformity topics.)
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
Viva scenarioStandard
Clinical prompt
“How would you minimise blood loss and transfusion in a major deformity spine operation?”
Practical approach
I would use a multimodal patient-blood-management approach across all three phases, because spine deformity surgery has the highest transfusion rate in orthopaedics, around 15%, owing to large exposures, cancellous bone bleeding, long operative times and the epidural venous plexus. Preoperatively, the highest-yield modifiable factor is anaemia, since a low preoperative haemoglobin is the strongest independent predictor of transfusion, so I would identify and treat iron-deficiency anaemia with oral or intravenous iron, and erythropoiesis-stimulating agents in selected patients, and manage any antiplatelet or anticoagulant therapy. Intraoperatively, the cornerstone is tranexamic acid, an antifibrinolytic that reduces bleeding, cell-saver volume and operative time, with higher weight-based dosing more effective in deformity surgery; its absence independently predicts transfusion. I would position the patient prone with a free abdomen on a suitable frame or table so the abdomen hangs free, which lowers caval pressure and reduces epidural venous engorgement and bleeding; use controlled hypotensive anaesthesia kept safe for cord perfusion; achieve meticulous haemostasis; use intra-operative cell salvage for high-volume cases; and stage very large reconstructions. Postoperatively, I would use a restrictive transfusion threshold, continue iron and monitor. I would also risk-stratify, because patients with low preoperative haemoglobin, a high-risk procedure, ASA III-IV, no TXA or older age most need the full bundle.
Key clinical points
Spine deformity surgery = highest transfusion rate in ortho (~15%)
Preop: optimise anaemia/iron (low Hb is the strongest predictor); manage anticoagulants
Intraop: TXA (cornerstone), free-abdomen prone positioning, hypotensive anaesthesia, cell salvage, staging
Postop: restrictive transfusion; risk-stratify (low Hb, high-risk, ASA III-IV, no TXA, age)
Common pitfalls
Not optimising anaemia before elective surgery
Omitting TXA
Compressed abdomen prone (increases epidural venous bleeding)
Further questions
“Strongest modifiable predictor of transfusion? - Low preoperative haemoglobin”
“Why position with a free abdomen? - Reduce caval pressure / epidural venous engorgement”
Viva scenarioStandard
Clinical prompt
“What is tranexamic acid and what is the evidence in spine surgery?”
Practical approach
Tranexamic acid is an antifibrinolytic agent: it is a lysine analogue that blocks the binding of plasminogen to fibrin, inhibiting fibrinolysis and thereby stabilising clot and reducing bleeding. It is the cornerstone pharmacological measure for reducing blood loss in spine surgery and is widely used. The evidence in adolescent idiopathic scoliosis surgery, from a network meta-analysis, shows that tranexamic acid significantly reduces intraoperative bleeding, cell-saver volume and operative time, and that higher weight-based dosing - a larger bolus with an infusion - is more effective than lower dosing, without a clear increase in complication rates, although complications were not uniformly reported. Separately, in a large cohort of major orthopaedic surgery, the absence of tranexamic acid was an independent predictor of red-cell transfusion, alongside low preoperative haemoglobin, a high-risk procedure and ASA III-IV status. So tranexamic acid should be used routinely in major spine surgery as part of a patient-blood-management bundle, with the dose tailored to the magnitude of the procedure, while applying the usual clinical judgement about contraindications. The take-home is that it is one of the highest-yield, lowest-cost measures available to reduce blood loss and transfusion.
Key clinical points
TXA = antifibrinolytic (lysine analogue; inhibits plasminogen-fibrin binding)
Reduces intraoperative bleeding, cell-saver volume and operative time
Higher weight-based dosing more effective in deformity surgery; no clear complication increase
Absence of TXA independently predicts transfusion - use routinely
Common pitfalls
Not using TXA in major spine surgery
Forgetting it is the cornerstone (highest-yield) pharmacologic measure
Ignoring weight-based dosing in deformity surgery
Further questions
“Mechanism of TXA? - Antifibrinolytic (blocks plasminogen binding to fibrin)”
“What does higher dosing achieve in AIS surgery? - Greater reduction in bleeding/cell-saver volume/op time”
Mnemonics & Memory Aids
Mnemonic
BLOOD
B
Blood management is multimodal (PBM bundle)
L
Low Hb? - optimise anaemia/iron preoperatively
O
Offer tranexamic acid (cornerstone antifibrinolytic)
O
Open abdomen free (prone positioning) - less venous engorgement
D
Diminish need: cell salvage, hypotension, haemostasis, staging; restrictive transfusion
Hook:BLOOD: Bundle (PBM), Low Hb optimise, Offer TXA, Open (free) abdomen prone, Diminish need (cell salvage/hypotension/restrictive).
Exam day cheat sheet
Blood Loss Management in Spine Surgery - Cheat Sheet
Why spine bleeds
- Large exposures, cancellous bone bleeding, long operative times, epidural venous plexus
- Highest transfusion rate in ortho (~15%; vs ~3-4% hip/knee)
- Deformity, multilevel and revision surgery the highest risk
Preoperative
- Identify/treat anaemia (iron +/- ESA) - low Hb is the strongest predictor
- Manage antiplatelet/anticoagulant agents
- Risk-stratify (Hb, procedure, ASA, age)
Intraoperative
- Tranexamic acid (cornerstone; higher weight-based dose in deformity)
- Free-abdomen prone positioning (reduce epidural venous engorgement)
- Hypotensive anaesthesia (safe for cord), haemostasis, cell salvage, staging
Postoperative
- Restrictive transfusion threshold (symptomatic/low Hb)
- Continue iron; monitor
- Patient blood management reduces transfusion exposure and risk